top of page
shutterstock_1219858987.jpg

PRODUCTS IN DEVELOPMENT

Living through and after cancer - not just surviving

We're building products that control and prevent the side effects of cancer treatment.

Lily

CHEMOTHERAPY INDUCED HAIR LOSS

Lily

A wearable, portable and comfortable device to prevent hair loss in chemotherapy patients

Interested in participating in or hosting a clinical trial? Be the first to know.

Join our list
Lily in Chair_edited.jpg
Lily Phone_edited.jpg

Clinical need

Hair loss is one of the most difficult aspects of cancer treatment. Chemotherapy attacks fast dividing cells, including hair cells, causing rapid hair loss within 2-3 weeks of starting treatment.

Product

A wearable, portable, cap that uses low-level compression therapy. Worn at every treatment session for 3 to 5 hours.

Next steps

Lily is currently entering in-human clinical trials in Europe.

Estimated launch

2024

Pre-clinical

Healthy volunteers

Pilot clinical trial

Pivotal clinical trial

FDA clearance

Lilac

CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY

Lilac

The world's first comfortable and portable device to prevent peripheral neuropathy

Interested in participating in or hosting a clinical trial? Be the first to know.

Join our list

Clinical need

CIPN is the loss of sensory and motor function caused by nerve damage associated with chemotherapy. A staggering 68% of all chemotherapy patients experience CIPN.

Product

A wearable glove and sock combination product that minimises drug delivery to the peripheries. 

Next steps

Lilac is currently in a pre-clinical trial with healthy volunteers.

Estimated launch

2026

Healthy volunteers

Pre-clinical trial

Pilot clinical trial

Pivotal clinical trial

FDA clearance

bottom of page